Aspire Biopharma Holdings, Inc. (ASBP) — Insider Trading & SEC Form 4 Filings
This page tracks SEC Form 4 insider transactions for Aspire Biopharma Holdings, Inc. (ASBP). Officers, directors, and 10%+ beneficial owners are required to report their ASBP trades to the SEC within two business days.
- 2 recent acquisitions ($7,800)
- 2 recent disposals ($7,800)
- 4 filings in this window
Recent ASBP insider transactions
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 5, 2025 | Fell Donald G. | Director | Buy | 10,500 | $4,095 |
| Jun 5, 2025 | Fell Donald G. | Director | Sell | 10,500 | $4,095 |
| Jun 4, 2025 | Fell Donald G. | Director | Buy | 9,500 | $3,705 |
| Jun 4, 2025 | Fell Donald G. | Director | Sell | 9,500 | $3,705 |
Frequently asked questions
- What is insider trading for ASBP?
- Insider trading refers to SEC Form 4 filings by officers, directors, and 10%+ owners of Aspire Biopharma Holdings, Inc.. These are public disclosures of legal transactions — open-market buys, sells, option exercises, and gifts — required within two business days of the trade.
- How many insider transactions has ASBP had recently?
- The most recent 4 insider filings for ASBP are shown below, with 2 acquisitions and 2 disposals in this window. Data is sourced directly from SEC EDGAR.
- Where does this insider data come from?
- All insider data is parsed from original SEC Form 4, Form 3, and Form 5 XML filings on EDGAR. Filings marked as amended or superseded are excluded from summary counts.